A recent survey of doctors from the U.S. finds that nearly two out of three believe it is permissible to use placebos, and one out of two U.S. doctors prescribe placebos to their patients.
Category: Regenerative Health
Has Technology Failed Us? Doctors Match Machines in Spotting Heart Disease
There are many aspects of what is sometimes called the “gold standard” of medicine that have been scrutinized by science and found to be lacking.
FDA Regulation Changes Threaten the Supplement Industry
Urgent Action Needed. The Time to Send Comments to the FDA is Now: comment period whether section 301 should be extended to include dietary supplements has been extended to November 25.
Heart Failure Hospitalizations Are Up 131% in Three Decades
The American Heart Association’s annual scientific session in New Orleans this month heard the presentation of a Drexel University study showing that the hospitalization rate for heart failure among older Americans increased dramatically over the past three decades.
The Link between Phthalates and Prescription Drugs
In August, Congress enacted a law banning the phthalates (esters of phthalic acid that are mainly added to plastics to increase their flexibility) in toys and other children’s products.
Johns Hopkins Clinicians Declare the Current RDA Guidelines Inadequate to Correct Vit D Deficiencies
According to an article in the current issue of Journal of Pediatrics, Johns Hopkins University researchers have termed the current RDA guidelines inadequate to correct the widely prevalent vitamin D deficiency in children suffering from cystic fibrosis. In their attempts to restore normal vitamin D levels, their trials used the recommended 50,000 IU of vitamin… Continue reading Johns Hopkins Clinicians Declare the Current RDA Guidelines Inadequate to Correct Vit D Deficiencies
Decision on BPA—Is the FDA Conclusion Deeply Flawed?
The topic of bisphenol A (BPA) regulation has been discussed in the September 9 and September 23 issues of Pulse of Health Freedom. Now thirty-six scientific advisers on an independent panel have concluded that the draft decision of the FDA on BPA used “unacceptable criteria for selecting data and depend(ed) heavily upon a key paper… Continue reading Decision on BPA—Is the FDA Conclusion Deeply Flawed?
Integrative Vision Award Bestowed upon AAHF President
The American College for Advancement in Medicine meeting was held in Las Vegas, October 15–19, 2008. Jonathan Wright, M.D., a distinguished clinician, educator, and ACAM member, introduced Hunter Lewis, president of American Association for Health Freedom. Then Jeanne Drisko, M.D., ACAM president and University of Kansas Medical School professor, presented Lewis the Integrative Vision Award… Continue reading Integrative Vision Award Bestowed upon AAHF President
The FDA Lets Thousands of Devices onto the Market Each Year with Only Cursory Review
When it comes to healthcare, is newer necessarily better? The idea that newer drugs are better than those that have been on the market for years has recently come under scrutiny. The higher costs of newer drugs, together along with their unknown side effects and contraindications, have led to the suggestion that one should never… Continue reading The FDA Lets Thousands of Devices onto the Market Each Year with Only Cursory Review
Wyeth at the Supreme Court, Justices Weigh a 100-Year-Old Right Enjoyed by Americans
The Supreme Court will hear the case of Wyeth v. Levine the week of November 3. The case involves Diana Levine, a guitarist and musician, who lost her arm (and her livelihood) due to gangrene from an improperly administered nausea drug made by Wyeth. She was awarded $6.7 million in damages in a Vermont court,… Continue reading Wyeth at the Supreme Court, Justices Weigh a 100-Year-Old Right Enjoyed by Americans